Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Teeft.i » - entrée « Disease duration »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Disease disease < Disease duration < Disease duration months  Facettes :

List of bibliographic references indexed by Disease duration

Number of relevant bibliographic references: 216.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
002833 (2013) Kristian Thorlund [Canada] ; Eric Druyts [Canada] ; J Antonio Avi A-Zubieta [Canada] ; Ping Wu [Canada] ; Edward J. Mills [Canada]Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings
002849 (2013) Muriel Elhai [France] ; Marine Meunier [France] ; Marco Matucci-Cerinic [Italie] ; Britta Maurer [Suisse] ; Gabriela Riemekasten [Allemagne] ; Tifenn Leturcq [France] ; Raffaele Pellerito [Italie] ; Carlos Alberto Von Mühlen [Brésil] ; Alessandra Vacca [Italie] ; Paolo Airo [Italie] ; Francesca Bartoli [Italie] ; Ginevra Fiori [Italie] ; Maria Bokarewa [Suède] ; Valeria Riccieri [Italie] ; Mike Becker [Allemagne] ; Jérôme Avouac [France] ; Ulf Müller-Ladner [Allemagne] ; Oliver Distler [Suisse] ; Yannick Allanore [France]Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
002857 (2013) Shumpei Yokota [Japon] ; Tomoyuki Imagawa [Japon] ; Masaaki Mori [Japon] ; Takako Miyamae [Japon] ; Syuji Takei [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Takuji Murata [Japon] ; Mari Miyoshi [Japon] ; Minako Tomiita [Japon] ; Norihiro Nishimoto [Japon] ; Tadamitsu Kishimoto [Japon]Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan
002869 (2013) Marieke H. Otten [Pays-Bas] ; Janneke Anink [Pays-Bas] ; Sandra Spronk [Pays-Bas] ; Lisette W A. Van Suijlekom-Smit [Pays-Bas]Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons
002912 (2013) P. Cornell [Royaume-Uni] ; S. Westlake [Royaume-Uni] ; P. Thompson [Royaume-Uni] ; S. Richards [Royaume-Uni]THU0596 Tight Control with Regular Review for Rheumatoid Arthritis in a DGH - Reduces the Use of Biologic Therapy According to Nice Guidelines even if Moderate Disease Activity was Treated
002913 (2013) R. Bakker [Pays-Bas] ; A. V. Ede [Pays-Bas] ; F. Lamers-Karnebeek [Pays-Bas] ; I. Meek [Pays-Bas] ; T. Jansen [Pays-Bas]THU0577 Protocol-Bvased Pharmacotherapy in Gout Delivered by Specialised Health Care Professional Under Supervision of a Rheumathologist is Similar but not Significantly Superior to Care as Usual
002932 (2013) S. Sanchez [Espagne] ; S. Iniesta [Espagne] ; M. P. Lisbona [Espagne] ; A. Pàmies [Espagne] ; M. Almirall [Espagne] ; J. Maymo [Espagne] ; J. Carbonell [Espagne]THU0461-HPR Global assessment of disease by the patient in the new ACR/EULAR remission criteria: Why do not fulfil the remission?
002935 (2013) B. Y. Hanaoka [États-Unis] ; L. C. Cleary [États-Unis] ; D. Long [États-Unis] ; C. P. Starnes [États-Unis] ; J. Duan [États-Unis] ; Q. Fan [États-Unis] ; C. A. Peterson [États-Unis] ; L. J. Crofford [États-Unis]THU0450 Relationship between the American College of Rheumatology (ACR) Classification Criteria of Functional Status and Clinical Predictors of Disability in Inflammatory Myopathies (IIM)
002936 (2013) B. Y. Hanaoka ; L. C. Cleary ; D. Long ; G. S. Chleboun [États-Unis] ; C. A. Peterson ; C. P. Starnes ; L. J. CroffordTHU0449 Utility of Ultrasound (US) in Assessing Skeletal Muscle Architecture in Idiopathic Inflammatory Myopathies (IIM)
002937 (2013) A. Ihata [Japon] ; D. Kishimoto [Japon] ; T. Uehara [Japon] ; M. Hama [Japon] ; R. Yoshimi [Japon] ; A. Ueda [Japon] ; M. Takeno [Japon] ; Y. Ishigatsubo [Japon]THU0448 The Profile of Musculoskeletal Ultrasonography in Patients with Adult Onset Still Disease.
002938 (2013) A. Kozlova [Russie] ; D. Konovalov [Russie] ; D. Abramov [Russie] ; A. Mitrofanova [Russie] ; A. Kislyakov [Russie] ; V. Roshchin [Russie] ; N. Miakova [Russie] ; I. Smirnova [Russie] ; E. Viktorova [Russie] ; A. Maschan [Russie] ; A. Shcherbina [Russie]THU0447 Insufficient Efficacy of Tocilizumab Therapy in Children with Castleman’s Disease
002946 (2013) A. Meyer [France] ; A. Theulin ; E. Chatelus ; C. Sordet ; R.-M. Javier ; B. Geny [France] ; J.-E. Gottenberg ; J. SibiliaTHU0412 Reactive hyperemia index (RHI) is associated with macrovascular disease and lung disease in systemic sclerosis
002947 (2013) A. M. Istrate [Espagne] ; E. De Miguel [Espagne] ; I. Felea [Espagne] ; M. Caracuel Ruíz [Espagne] ; E. Collantes-Estevéz [Espagne]THU0411 Utility of ultrasound scores in assessment enthesitis on anti-TNF therapy of spondyloarthritis patients
002948 (2013) Y. Takakuwa ; H. Yamada ; H. Ito ; S. Ooka ; Y. Yamasaki ; H. Nakano ; M. Hiida ; Y. Kurihara [Japon] ; S. OzakiTHU0410 Characterisation of interstitial lung disease associated with adult still’s disease
002966 (2013) H. J. Lachmann [Royaume-Uni] ; J. D. Gillmore [Royaume-Uni] ; A. D. Wechalekar [Royaume-Uni] ; S. D. Gibbs [Royaume-Uni] ; J. H. Pinney [Royaume-Uni] ; D. M. Rowczenio [Royaume-Uni] ; H. Trojer [Royaume-Uni] ; T. Lane [Royaume-Uni] ; C. P. Venner [Royaume-Uni] ; S. M. Banypersad [Royaume-Uni] ; J. A. Gilbertson [Royaume-Uni] ; F. T. Hunt [Royaume-Uni] ; D. Gopaul [Royaume-Uni] ; D. F. Hutt [Royaume-Uni] ; N. Wassef [Royaume-Uni] ; M. B. Pepys [Royaume-Uni] ; P. N. Hawkins [Royaume-Uni]THU0379 A 20 year single centre experience of aa amyloidosis demonstrating changes in its epidemiology
002978 (2013) S. Ozen ; E. Demirkaya [Turquie] ; G. Amaryan [Arménie] ; I. Koné-Paut [France] ; P. Woo [Royaume-Uni] ; Y. Uziel [Israël] ; M. Finetti [Italie] ; P. Quartier [France] ; C. Modesto [Espagne] ; E. Papadopoulou-Alataki [Grèce] ; S. Nielsen [Danemark] ; M. Hofer [Suisse] ; A. Polat [Turquie] ; T. Turker [Turquie] ; A. Insalaco [Italie] ; L. Cantarini [Italie] ; S. M. Al-Mayouf [Arabie saoudite] ; J. Frenkel [Pays-Bas] ; H. Ozdogan [Turquie] ; N. Ruperto [Italie] ; M. Gattorno [Italie]THU0334 Differences in the features of familial mediterranean fever among patients from europe as compared to those from the eastern mediterranean countries
002979 (2013) S. Vastert ; W. De Jager [Pays-Bas] ; B. J. Noordman [Pays-Bas] ; D. Holzinger [Allemagne] ; W. Kuis ; B. Prakken ; N. WulffraatTHU0333 Effectiveness and long-term follow up of recombinant IL-1RA as first line therapy in newly onset juvenile idiopathic arthritis
002980 (2013) R. Carrasco [Royaume-Uni] ; L. R. Wedderburn [Royaume-Uni] ; H. E. Foster ; E. Baildam ; J. Gardner-Medwin [Royaume-Uni] ; A. Chieng [Royaume-Uni] ; J. Davidson [Royaume-Uni] ; W. Thomson [Royaume-Uni] ; K. Hyrich [Royaume-Uni]THU0332 Predictors of poor growth in children with early juvenile idiopathic arthritis: Results from the childhood arthritis prospective study (CAPS)
002981 (2013) R. Campanilho-Marques [Portugal] ; F. Ramos [Portugal] ; J. Romeu [Portugal] ; J. A. Pereira Da Silva [Portugal]THU0331 Management of osteoporosis in children: Experience from a pediatric rheumatology center
002982 (2013) E. Theander [Suède] ; T. Mandl [Suède]THU0316 Salivary Gland Ultrasonography in Primary SjöGren’s Syndrome. Association with Lymphoma Risk Markers and Longitudinal Follow-Up.
002986 (2013) G. Horneff ; K. Minden [Allemagne] ; I. Foeldvari [Allemagne]THU0310 Performance of the juvenile arthritis disease activity score JADAS compared to the acr pediatric measures of response in 1470 juvenile idiopathic arthritis patients

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Disease duration" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Disease duration" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Disease duration
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021